SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Vivimed Labs
BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01013|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 27, 16:15
366.35
-0.15 (-0.04%)
VOLUME 2,218
LIVE
NSE
Nov 27, 16:15
365.00
-0.85 (-0.23%)
VOLUME 13,550
Announcements on Vivimed Labs

13th-Nov-2014 14:50Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has submitted to the Exchange a copy of Q2 FY2015 Earning Presentation.

13th-Nov-2014 14:46Source: BSE

Vivimed Labs- Earnings Presentation

Vivimed Labs Ltd has submitted to BSE a copy Earnings Presentation for - "Q2 FY 2015".

12th-Nov-2014 21:21Source: BSE

Vivimed Labs- Outcome of Board Meeting

Vivimed Labs Ltd has informed BSE regarding Outcome of Board Meeting held on November 12, 2014.

12th-Nov-2014 19:05Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2014.

12th-Nov-2014 18:57Source: BSE

Vivimed Labs- Financial Results & Limited Review for Sept 30, 2014

Vivimed Labs Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014.

31st-Oct-2014 17:26Source: BSE

Vivimed Labs- Closure of Trading Window

Vivimed Labs Ltd has informed BSE that the Board meeting for considering / approving the un audited Financial Results of the Company for the quarter & half year ended September 30, 2014 will be held o...

31st-Oct-2014 13:54Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange that the Trading Window shall, pursuant to the Code of Conduct for prevention of Insider Trading under the SEBI (Prohibition of Insider Trading) Regulati...

21st-Oct-2014 13:06Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Sujatha Varalwar has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

21st-Oct-2014 10:04Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Sandeep Varalwar has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

14th-Oct-2014 13:05Source: BSE

Vivimed Labs- Shareholding Pattern For September 30, 2014

Vivimed Labs Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014.

1 2 3 4 5 Next >>
Quick Links for Vivimed Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.